First-Line Therapy in Uncomplicated Malaria: A Case Review CME

Select Content Type
Resources
Authored By
Shalina MedSpace
Authored On
Interests
Cardiology
Dermatology
Emergency Medicine
Endocrinology
ENT
Gastroenterology
Hematology
Immunology Allergy & Inflammation
Infectious Disease & Vaccines
Internal/Family Medicine
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopedic
Pain & Anesthesiology
Pediatric Medicine
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology & Nephrology
Speciality
Cardiology
Dentistry
Dermatology
Emergency Medicine
Endocrinology
ENT
Gastroenterology
Geriatrics
Hematology
Immunology Allergy & Inflammation
Infectious Disease & Vaccines
Internal/Family Medicine
Medical Genetics
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopedic
Pain & Anesthesiology
Pathology
Pediatric Medicine
Pharmacology
Psychiatry
Public Health
Pulmonology
Radiology
Rheumatology
Surgery
Urology & Nephrology
Thumbnail Image
shalartem_thumbnail
Detail Image
Shalartem_detailed
Book Detail
Upload PDF
Shal'Artem case CME- Dec 2024.pdf (1.04 MB)
Actions
Download in App
Promotional Categories
Featured
Countries of release
Angola
Central African Republic (CAR)
Democratic Republic of the Congo (DRC)
Ghana
India
Kenya
Nigeria
UAE
Zambia
IS_Ebsco
false
Description

What is the recommended first-line treatment for uncomplicated malaria? Discover the answer in this case-based CME featuring a 28-year-old male with intermittent fever every 48 hours, weakness, and confirmed Plasmodium falciparum infection. The treatment was guided by WHO 2023 malaria recommendations. Read the case to learn which ACT was chosen as the first-line therapy, how effective it proved to be, and the final outcome.

Published Date